# clm_3B9F3E529762

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 665,700,000 United States dollar  
valid_from: 2014-06-30  
valid_to: 2014-09-30  
published: 2014-08-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_D15D4A6E6B04  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly revenue: 665,700,000 United States dollar", as of 2014-06-30 (until 2014-09-30). Claim clm_3B9F3E529762, https://asof.is/claim/clm_3B9F3E529762, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217614000035/0001532176-14-000035-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:Revenues in 10-Q Q2 FY2014, filed 2014-08-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217614000035/0001532176-14-000035-index.htm (primary, SEC EDGAR 10-Q Q2 FY2014, published 2014-08-05)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 625,740,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_3B9F3E529762](/claim/clm_3B9F3E529762.md) | [clm_6885E2367C01](/claim/clm_6885E2367C01.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.